SERVICES

TRANSACTIONAL DUE DILIGENCE
FDA Regulatory Counsel provides practical, business-minded due diligence for deal teams. We understand that each transaction comes with its own ecology, and we deliver insight accordingly.

Provide high level industry insight where regulatory issues affect business outcomes

Review and advise on compliance history and potential vulnerabilities

Assess regulatory risk in order to support informed business decisions

Draft credit and purchase agreement language, including R&W, covenants, notice, and post-closing requirements 

Perform target company compliance analyses to support informed business decisions

Advise on ancillary regulatory requirements (transfers, registrations, contracts)

Advise on prospective liability from regulatory enforcement or consumer action

Vet prospective deals based on industry posture and target companies/products

SCIENTIFIC AND MEDICAL EXPERTISE

FDARC also provides insight on complex matters tied to FDA-regulated products and companies

in corporate and litigation issues.

Schedule a courtesy consultation about the value we can add to your work.  

Questions? Contact us

 We are here to assist. 

1717 K St., NW

Suite 900

Washington, DC 20006

202.465.8669 o

202.714.0856 m

200 East Randolph St.

Suite 5100

Chicago, IL 60601

312.485.7276 o

419.466.5512 m

PHARMACY LAW COUNSEL

Regulatory Means Business.

TM

© 2018 by Pharmacy Law Counsel LLP

DISCLAIMER

This site is not intended to be legal advice. Contacting the firm or reading the materials on the site does not create an attorney-client relationship. No confidential information should be sent over the internet. Past results do not predict future outcomes as each situation has to stand on its own. Melissa Gilmore is licensed to practice law in the District of Columbia, New York (inactive), and California (inactive). Donato J. Borrillo is licensed to practice law in Ohio.